FDA gives emergency authorization to COVID-19 drug
May 4, 2020
Remdesivir is the first anti-viral drug that has been shown to benefit patients with COVID-19 in a randomized clinical trial.
Category
May 4, 2020
Remdesivir is the first anti-viral drug that has been shown to benefit patients with COVID-19 in a randomized clinical trial.
April 30, 2020
Early results of a COVID-19 treatment study being conducted in San Antonio shows a faster recovery time and fewer deaths for patients.
April 23, 2020
The $100,000 gift will support on-campus COVID-19 testing.
April 20, 2020
To understand and prevent COVID-19-induced heart disease, researchers will follow recovered patients.
April 17, 2020
Dr. Barbara Taylor, Infectious Diseases, is leading the COVID-19 Health Transition Team.
April 17, 2020
A third-year medical student is eager to integrate her experiences from global and local service programs into a future career as a dermatologist.